Liping Yu Selected Research

Fibrosis (Cirrhosis)

10/2023	99mTc-HFAPi imaging identifies early myocardial fibrosis in the hypertensive heart.
8/2021	Comparative and Combinatorial Effects of Resveratrol and Sacubitril/Valsartan alongside Valsartan on Cardiac Remodeling and Dysfunction in MI-Induced Rats.
1/2019	Dietary flaxseed protects against ventricular arrhythmias and left ventricular dilation after a myocardial infarction.
2/2016	Resveratrol is equipotent to perindopril in attenuating post-infarct cardiac remodeling and contractile dysfunction in rats.
10/2013	Reduced hemodynamic load aids low-dose resveratrol in reversing cardiovascular defects in hypertensive rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liping Yu Research Topics

Disease

113	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2024 - 01/2002
25	Neoplasms (Cancer) 05/2024 - 04/2006
15	Autoimmune Diseases (Autoimmune Disease) 02/2024 - 01/2002
14	Celiac Disease (Celiac Sprue) 01/2022 - 09/2003
12	Inflammation (Inflammations) 03/2024 - 12/2008
11	Insulinoma 01/2022 - 03/2005
10	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2008
8	Thyroid Diseases (Thyroid Disease) 03/2023 - 04/2005
8	Cardiomegaly (Heart Hypertrophy) 06/2018 - 02/2010
8	Addison Disease (Addison's Disease) 10/2015 - 01/2005
7	Infections 10/2023 - 07/2011
7	Hypertrophy 02/2017 - 02/2010
6	Disease Progression 12/2023 - 11/2003
6	Hypertension (High Blood Pressure) 07/2023 - 10/2013
6	Myocardial Infarction 12/2021 - 02/2016
6	Heart Failure 08/2021 - 07/2011
5	Stroke (Strokes) 04/2024 - 07/2016
5	Fibrosis (Cirrhosis) 10/2023 - 10/2013
5	Hyperglycemia 07/2023 - 01/2007
5	COVID-19 01/2023 - 10/2020
5	Obesity 01/2023 - 01/2007
5	Glioma (Gliomas) 10/2017 - 09/2011
4	Pneumonia (Pneumonitis) 07/2023 - 04/2020
4	Tic Disorders (Tic Disorder) 11/2022 - 01/2020
4	Body Weight (Weight, Body) 01/2021 - 05/2010
4	Diabetes Mellitus 01/2020 - 10/2013
4	Essential Hypertension 04/2018 - 02/2010
4	Muscular Dystrophies (Muscular Dystrophy) 10/2016 - 01/2010
3	Genetic Risk Score 02/2024 - 01/2019
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2019
3	Infarction (Infarctions) 12/2021 - 02/2016
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 06/2014
3	Blindness (Hysterical Blindness) 10/2019 - 01/2017
3	Leber Congenital Amaurosis 01/2019 - 01/2017
3	Anaphylaxis (Anaphylactic Shock) 01/2004 - 10/2002
2	Wounds and Injuries (Trauma) 07/2023 - 06/2016
2	Hypoglycemia (Reactive Hypoglycemia) 07/2023 - 03/2005
2	Confusion (Bewilderment) 07/2023 - 05/2010
2	Liver Neoplasms (Liver Cancer) 06/2023 - 10/2010
2	Diabetic Nephropathies (Diabetic Nephropathy) 05/2023 - 10/2013
2	Breast Neoplasms (Breast Cancer) 03/2023 - 10/2022
2	Lung Neoplasms (Lung Cancer) 03/2023 - 04/2010
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 11/2022 - 05/2022
2	Abdominal Pain (Pain, Abdominal) 10/2021 - 02/2002
2	Fever (Fevers) 10/2021 - 02/2002

Drug/Important Bio-Agent (IBA)

83	AutoantibodiesIBA 02/2024 - 01/2002
51	Insulin (Novolin)FDA Link 02/2024 - 04/2002
25	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2002
17	AntigensIBA 01/2024 - 01/2005
17	AntibodiesIBA 03/2023 - 03/2002
16	Peptides (Polypeptides)IBA 09/2023 - 05/2002
13	AutoantigensIBA 02/2024 - 01/2002
9	Steroid 21-Hydroxylase (21 Hydroxylase)IBA 03/2023 - 01/2005
9	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2003
9	EpitopesIBA 01/2020 - 01/2002
9	ResveratrolIBA 02/2017 - 02/2010
8	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2022 - 01/2010
8	Class 8 Receptor-Like Protein Tyrosine PhosphatasesIBA 04/2017 - 03/2002
7	Zinc Transporter 8IBA 01/2022 - 05/2011
6	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2023 - 04/2005
6	TransglutaminasesIBA 01/2022 - 09/2003
6	ProinsulinIBA 01/2021 - 03/2005
5	C-PeptideIBA 01/2021 - 03/2005
5	insulin B (9-23)IBA 01/2020 - 11/2003
5	PolyphenolsIBA 02/2017 - 05/2010
4	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 02/2016
4	Blood Glucose (Blood Sugar)IBA 01/2024 - 01/2013
4	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 08/2004
4	Iodide Peroxidase (Deiodinase)IBA 05/2021 - 04/2005
4	LigandsIBA 01/2020 - 04/2006
4	ZincIBA 01/2020 - 06/2011
4	Monoclonal AntibodiesIBA 01/2020 - 01/2013
4	Phosphoric Monoester Hydrolases (Phosphatases)IBA 03/2011 - 01/2002
3	CholesterolIBA 03/2024 - 01/2013
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2023 - 07/2006
3	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 01/2012
3	Hemoglobins (Hemoglobin)IBA 07/2023 - 01/2021
3	LipidsIBA 01/2022 - 01/2017
3	AntioxidantsIBA 10/2021 - 12/2014
3	Therapeutic UsesIBA 11/2020 - 12/2014
3	Antihypertensive Agents (Antihypertensives)IBA 07/2020 - 07/2016
3	CytokinesIBA 04/2020 - 04/2012
3	HLA-DR Antigens (HLA-DR)IBA 01/2020 - 09/2006
3	Amino Acids FDA Link 01/2020 - 10/2002
3	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2019 - 07/2015
3	Dystroglycans (Dystroglycan)IBA 10/2016 - 08/2013
3	MicroRNAs (MicroRNA)IBA 01/2014 - 07/2011
3	Tyrosine (L-Tyrosine)FDA Link 06/2005 - 01/2002
2	beta-GlucansIBA 07/2023 - 07/2020
2	C-Reactive ProteinIBA 07/2023 - 01/2019
2	fibrin fragment D (D-dimer)IBA 07/2023 - 10/2021
2	Immunoglobulin A (IgA)IBA 01/2023 - 09/2003
2	VaccinesIBA 01/2023 - 01/2023
2	Pattern Recognition ReceptorsIBA 12/2022 - 01/2021
2	tyramine-deoxysorbitolIBA 05/2022 - 01/2020
2	preproinsulinIBA 01/2022 - 01/2017

Therapy/Procedure

20	Therapeutics 04/2024 - 05/2002
5	Immunotherapy 01/2021 - 11/2003
4	Palliative Care (Palliative Therapy) 11/2023 - 01/2022
2	Drug Therapy (Chemotherapy) 05/2024 - 01/2012